Genevec Contra
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Genevec Contra and buy or sell other stocks, ETFs, and their options commission-free!About GNVC
GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform.
CEODouglas J. Swirsky, MBA, CPA
CEODouglas J. Swirsky, MBA, CPA
Employees—
Employees—
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded1992
Founded1992
Employees—
Employees—
GNVC Key Statistics
Market cap16.36M
Market cap16.36M
Price-Earnings ratio-1.97
Price-Earnings ratio-1.97
Dividend yield—
Dividend yield—
Average volume8.00K
Average volume8.00K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$10.44
52 Week high$10.44
52 Week low$2.70
52 Week low$2.70
Stock Snapshot
The current Genevec Contra(GNVC) stock price is $7.19, with a market capitalization of 16.36M. The stock trades at a price-to-earnings (P/E) ratio of -1.97.
During the trading day, Genevec Contra(GNVC) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Genevec Contra(GNVC) stock has reached 0, versus its average volume of 8K.
The stock's 52-week range extends from a low of $2.70 to a high of $10.44.
The stock's 52-week range extends from a low of $2.70 to a high of $10.44.